Jen Goldsack is the Executive Director of the Digital Medicine Society (DiMe). Previously, Jen spent several years at the Clinical Trials Transformation Initiative (CTTI) where she led development and implementation several projects within CTTI’s Mobile Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System. Jen holds a master’s degree in chemistry from the University of Oxford, England, a masters in the history and sociology of medicine from the University of Pennsylvania, and an MBA from the George Washington University.